We are live on
!
Find out more
EMG
ETF Managers Group Portfolio holdings
AUM
$3.1B
Turnover
42.86%
1-Year Est. Return
17.12%
This Fund
S&P 500
This Quarter
Est. Return
+5.57%
1 Year Est. Return
-17.12%
3 Year Est. Return
+77.69%
5 Year Est. Return
+63.88%
10 Year Est. Return
–
AUM
$6.13B
AUM Growth
+$505M
(+9%)
Cap. Flow
+$205M
Cap. Flow
% of AUM
3.34%
Top 10 Holdings %
Top 10 Hldgs %
19.96%
Holding
831
New
162
Increased
239
Reduced
241
Closed
184
Avg Time Held
1.7
years
Top 10 Avg Time Held
0.4
years
Top 20 Avg Time Held
0.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VALT
ETFMG Sit Ultra Short ETF
VALT
|
+$79.6M |
| 2 |
Tilray
TLRY
|
+$56.8M |
| 3 |
Aurora Cannabis
ACB
|
+$54.4M |
| 4 |
Canopy Growth
CGC
|
+$51.6M |
| 5 |
KNBE
KnowBe4, Inc. Class A Common Stock
KNBE
|
+$51.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$187M |
| 2 |
APHA
Aphria Inc. Common Shares
APHA
|
+$182M |
| 3 |
Hecla Mining
HL
|
+$43.6M |
| 4 |
Mativ Holdings
MATV
|
+$21.5M |
| 5 |
BlackBerry
BB
|
+$21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 42.87% |
| 2 | Healthcare | 15.14% |
| 3 | Materials | 14.7% |
| 4 | Financials | 7.38% |
| 5 | Consumer Staples | 5.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
576
Blackbaud
BLKB
$2.33B
| $362K | 0.01% |
4,669
-366
| -7% | -$26.4K |
2020 Q2
4 quarters
|
|
577
AbbVie
ABBV
$501B
| $361K | 0.01% |
3,211
-4,299
| -57% | -$484K |
2020 Q1
5 quarters
|
|
578
PagerDuty
PD
$1.36B
| $357K | 0.01% |
7,993
-537
| -6% | -$21.8K |
2020 Q2
4 quarters
|
|
579
Johnson & Johnson
JNJ
$610B
| $356K | 0.01% |
2,170
-7,158
| -77% | -$1.19M |
2019 Q1
9 quarters
|
|
580
Vaxcyte
PCVX
$10.3B
| $342K | 0.01% |
15,155
-451
| -3% | -$9.23K |
2020 Q3
3 quarters
|
|
581
DELISTED
Dynavax Technologies
DVAX
| $334K | 0.01% |
33,799
-898
| -3% | -$8.16K |
2020 Q2
4 quarters
|
|
582
Array Technologies
ARRY
$550M
| $328K | 0.01% |
+20,147
| New | +$425K |
2021 Q2
0 quarters
|
|
583
ARS Pharmaceuticals
SPRY
$405M
| $325K | 0.01% |
10,295
-431
| -4% | -$13.8K |
2021 Q1
1 quarter
|
|
584
DELISTED
Vaxart
VXRT
| $298K | ﹤0.01% |
36,071
-19
| -0.1% | -$133 |
2020 Q2
4 quarters
|
|
585
8x8 Inc
EGHT
$299M
| $296K | ﹤0.01% |
10,512
-677
| -6% | -$19.2K |
2020 Q2
4 quarters
|
|
586
Hanover Insurance
THG
$7.95B
| $294K | ﹤0.01% |
2,160
-1,396
| -39% | -$191K |
2020 Q2
4 quarters
|
|
587
DELISTED
Meridian Bioscience Inc
VIVO
| $288K | ﹤0.01% |
12,780
-35,534
| -74% | -$754K |
2020 Q2
4 quarters
|
|
588
Kopin
KOPN
$688M
| $284K | ﹤0.01% |
32,013
+4,415
| +16% | +$36.6K |
2021 Q1
1 quarter
|
|
589
Sohu.com
SOHU
$329M
| $276K | ﹤0.01% |
14,906
-1,214
| -8% | -$21.6K |
2018 Q3
11 quarters
|
|
590
Huya Inc
HUYA
$528M
| $270K | ﹤0.01% |
15,288
+4,345
| +40% | +$72.8K |
2019 Q2
8 quarters
|
|
591
Sea Limited
SE
$59.7B
| $269K | ﹤0.01% |
938
-277
| -23% | -$70.3K |
2019 Q2
8 quarters
|
|
592
Arcturus Therapeutics
ARCT
$320M
| $268K | ﹤0.01% |
7,763
-10,058
| -56% | -$340K |
2020 Q2
4 quarters
|
|
593
Applovin
APP
$93.5B
| $265K | ﹤0.01% |
+3,181
| New | +$220K |
2021 Q2
0 quarters
|
|
594
Cheetah Mobile
CMCM
$72.3M
| $262K | ﹤0.01% |
22,721
-9,296
| -29% | -$104K |
2018 Q3
11 quarters
|
|
595
Enanta Pharmaceuticals
ENTA
$334M
| $261K | ﹤0.01% |
5,957
-222
| -4% | -$10.9K |
2020 Q2
4 quarters
|
|
596
Hello Group
MOMO
$685M
| $261K | ﹤0.01% |
16,686
-503
| -3% | -$7.41K |
2018 Q3
11 quarters
|
|
597
Immersion
IMMR
$237M
| $257K | ﹤0.01% |
29,489
-17,107
| -37% | -$147K |
2017 Q2
16 quarters
|
|
598
Turtle Beach Corp
TBCH
$290M
| $257K | ﹤0.01% |
7,826
-7,844
| -50% | -$238K |
2018 Q2
12 quarters
|
|
599
Huckleberry.ai, Inc. Class B Common Stock
HUCK
$151M
| $252K | ﹤0.01% |
3,030
-88
| -3% | -$5.76K |
2020 Q2
4 quarters
|
|
600
PTC
PTC
$21B
| $245K | ﹤0.01% |
+1,731
| New | +$237K |
2021 Q2
0 quarters
|
|
Similar funds
PFM
HT
JCG
QA
BFG
IMOV
ETF Managers Group's Q2 2021 Portfolio in Review
As of Q2 2021, ETF Managers Group held 831 positions worth $6.13B, up 9% from $5.63B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
ETF Managers Group deployed $205M of net new capital in Q2 2021, opening 162 new positions and adding to 239 existing holdings. Its largest new stake was KnowBe4, Inc. Class A Common Stock: 2,250,843 shares worth $74.9M.
By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 42% a quarter earlier, followed by Healthcare and Materials.
On the sell side, the largest reduction was Hecla Mining, an estimated $43.6M trimmed.
- ETF Managers Group's largest Q2 2021 buy was KnowBe4, Inc. Class A Common Stock: 2,250,843 shares worth $74.9M.
- ETF Managers Group added most to ETFMG Sit Ultra Short ETF in Q2 2021, an estimated $79.6M increase.
- ETF Managers Group's biggest Q2 2021 reduction was Hecla Mining, cutting an estimated $43.6M.
- ETF Managers Group fully exited GW Pharmaceuticals Plc American Depositary Shares in Q2 2021, selling an estimated $187M.
- ETF Managers Group's ten largest holdings make up 20% of its $6.13B portfolio in Q2 2021.
- ETF Managers Group opened 162 new positions and closed 184 in Q2 2021.
- ETF Managers Group's portfolio value rose 9% quarter-over-quarter to $6.13B.
Based on ETF Managers Group's 13F filing for Q2 2021, filed 16 Aug 2021.